Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3.

Consogno G, Manici S, Facchinetti V, Bachi A, Hammer J, Conti-Fine BM, Rugarli C, Traversari C, Protti MP.

Blood. 2003 Feb 1;101(3):1038-44. Epub 2002 Sep 19.

PMID:
12393675
2.

Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s).

Imro MA, Manici S, Russo V, Consogno G, Bellone M, Rugarli C, Traversari C, Protti MP.

Cancer Res. 1999 May 15;59(10):2287-91.

3.

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

Manici S, Sturniolo T, Imro MA, Hammer J, Sinigaglia F, Noppen C, Spagnoli G, Mazzi B, Bellone M, Dellabona P, Protti MP.

J Exp Med. 1999 Mar 1;189(5):871-6.

4.

Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.

Imro MA, Dellabona P, Manici S, Heltai S, Consogno G, Bellone M, Rugarli C, Protti MP.

Hum Gene Ther. 1998 Jun 10;9(9):1335-44.

PMID:
9650618
5.

CD14+ CD34+ peripheral blood mononuclear cells migrate across endothelium and give rise to immunostimulatory dendritic cells.

Ferrero E, Bondanza A, Leone BE, Manici S, Poggi A, Zocchi MR.

J Immunol. 1998 Mar 15;160(6):2675-83.

Supplemental Content

Loading ...
Support Center